arrow
M

Mariana Castells

brigham and women’s hospital
H指数:74
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study

阿伐普利坦(Avapritinib)可改善惰性系统性肥大细胞增多症患者的皮肤受累情况:随机、Ⅱ期、干预性PIONEER研究结果

2026-02-120
PRE
Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy

Betalactam预测因子的开发: 一种用于降低低风险Betalactam过敏患者标签的临床决策工具。青霉素过敏的初步验证

2026-01-190
OAAI
Evolution of Mast Cell Research Associated with the Laboratory of Allergic Diseases: 1985-2022 Presented at 2023 NIAID Symposium

与过敏性疾病实验室相关的肥大细胞研究进展:1985-2022(2023年NIAID研讨会报告)

2025-07-070
PRE
Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper

嗜碱性粒细胞活化试验:连接过敏与肿瘤学,用于过敏肿瘤学的诊断、治疗和预后应用:EAACI立场文件

2025-06-120
OAAI
Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosis

长期使用avapritinib治疗惰性系统性肥大细胞增生症显示出持续的疗效和生存质量改善,以及良好的安全性。

2025-05-220
PREAI
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
2024-12-012
OAAI